logo
  • About
  • R&D
  • Pipeline
  • Investors
  • News
  • Contact
  • Primary Sclerosing Cholangitis
  • Nonalcoholic Steatohepatitis (NASH)
  • (NASH) דלקת כבד על רקע שומני
Investor Relations

Investor Relations

  • Overview
  • News & Events
    • News
    • Events
    • Presentations
    • Contact IR
    • Email Alerts
  • Financials & Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock
    • Stock Quote & Chart
    • Historical Stock Price
    • Analyst Coverage
  • Corporate Governance
    • Board Committees
    • Board of Directors
    • Leadership
    • Documents
    • SEC Filings

    • Annual Reports

    • Quarterly Results

NASDAQCMMB
YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
S-8Securities offered to employees pursuant to employee benefit plansAug 15, 2022Open Securities offered to employees pursuant to employee benefit plans in HTML.Open Securities offered to employees pursuant to employee benefit plans in DOC file.Open Securities offered to employees pursuant to employee benefit plans in PDF file.Open Securities offered to employees pursuant to employee benefit plans in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 25, 2022Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.

Investor Relations

Chemomab Therapeutics Ltd.

Kiryat Atidim, Building 7
Tel Aviv, Israel 6158002

Follow us on

Subscribe to Alerts

Irina Koffler

LifeSci Advisors, LLC

IR@Chemomab.com

Phone: +1-917-734-7387

Barbara Lindheim

Consulting Vice President

Investor & Public Relations

barbara@chemomab.com

Phone: +1-917-355-9234

Copyright © Chemomab. All rights reserved.

Privacy Policy Terms of Service

Designed and built by Studio Praktik